drugset
drugset / Trial / NCT02955706

Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease

NCT02955706 ↗

Phase 4 Completed 265 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

clinical trial to assess the efficacy of Acetyl-L-carnitine

Timeline

Start
2016-04-01
Primary completion
2018-09-29
Completion
2019-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule — —

Indications

Alzheimer disease